Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue

Movement Disorders

Volumn 18, Issue 8, 2003, Pages 928-932

  Cochen, Valérie ^a   Ribeiro, Maria Joao ^b   Nguyen, Jean Paul ^c   Gurruchaga, Jean Marc ^c   Villafane, Gabriel ^c   Loc'h, Christian ^b   Defer, Gilles ^c,d   Samson, Yves ^b,e   Peschanski, Marc ^c   Hantraye, Philippe ^a   Cesaro, Pierrre ^c   Remy, Philippe ^a,b,c  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b DIF   (France)

^c FACULTÉ DE MÉDECINE   (France)

^d Service de Neurologie   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

CIT; Dopamine transporter; Fetal transplantation; Parkinson; PET

Indexed keywords

6 FLUORODOPA F 18; BROMINE; DOPAMINE TRANSPORTER; LEVODOPA; LIGAND; TRACER;

ADULT; ARTICLE; BRAIN CELL; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DENSITY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRUG UPTAKE; FEMALE; FETUS CELL; HUMAN; IMPLANTATION; INNERVATION; LIGAND BINDING; MALE; MESENCEPHALON; NERVE ENDING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; TISSUE GRAFT;

AGED; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FETAL TISSUE TRANSPLANTATION; FLUORODEOXYGLUCOSE F18; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MESENCEPHALON; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 10744219751     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10463     Document Type: Article

References (20)

1. Hagell P, Brundin P. Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 2001;60:741-752.
2. 18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995;38:580-588.
3. Gjedde A, Reith J, Dyve S, et al. Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci U S A 1991;88:2721-2725.
4. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 1996;16:436-447.
5. Ribeiro MJ, Vidailhet M, Loc'h C, et al. Dopaminergic function and dopamine transporter density assessed with PET in Parkinson's disease. Arch Neurol 2002;59:580-586.
6. Langston JW, Widner H, Goetz C, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
7. Defer G, Gény C, Ricolfi F, et al. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 1996;119:41-50.
8. Lozano AM, Lang AE, Galvez-Jimenez N, et al. Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 1995;346:1383-1387.
9. Mazoyer B, Trebossen R, Deutch R, Casey M, Blohm K. Physical characteristics of the ECAT 953B/31: a new high resolution brain positron tomograph. IEEE Trans Med Imaging 1991;10:499-504.
10. Nurmi E, Bergman J, Eskola O, et al. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study. J Cereb Blood Flow Metab 2000;20:1604-1609.
11. Brooks DJ, Salmon EP, Mathias CJ, et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain 1990;113:1539-1552.
12. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985;5:584-590.
13. Wenning GK, Odin P, Morrish P, et al. Short- and long-term survival and function of unilateral intrastiatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997;42:95-107.
14. Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995;38:379-388.
15. Hagell P, Schrag A, Piccini P, et al. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 1999;122:1121-1132.
16. Piccini P, Lindvall O, Bjorklund A, et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000;48:689-695.
17. Olanow CW, Kordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 1996; 19:102-109.
18. Elsworth JD, Brittan MS, Taylor JR, et al. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated Parkinsonian monkeys. Cell Transplant 1996;5:315-325.
19. Brownell AL, Livni E, Galpern W, Isacson O. In vivo PET imaging in rat of dopamine terminals reveals functional neural transplants. Ann Neurol 1998;43:387-390.
20. Fujita M, Nishino H, Kumazaki M, Shimada S, Tohyama M, Nishimura T. Expression of dopamine transporter mRNA and its binding site in fetal nigral cells transplanted into the striatum of 6-OHDA lesioned rat. Brain Res Mol Brain Res 1996;39: 127-136.